Pfizer, Novartis lead pharma spending spree on gene therapy production

Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world's priciest medicines.

from Reuters: Health News https://ift.tt/37ITt51
via IFTTT